Kinetics of amyloid aggregation of mammal apomyoglobins and correlation with their amino acid sequences.

The research discusses the rate of protein aggregation and amyloid formation in different types of mammal apomyoglobins and how it’s affected by their specific amino acid sequences.

Introduction

Amyloid aggregation refers to the process whereby normally soluble proteins are deposited as insoluble aggregates, often referred to as amyloid. This happens in certain protein deposition disorders, where the normally soluble protein unfolds and aggregates, producing insoluble amyloid. Certain genetic mutations are known to alter the rate of protein aggregation by changing factors such as hydrophobicity, a protein’s propensity to convert from an alpha-helical to beta sheet conformation, and charge.

Objective of the Study

• The study aimed to examine the aggregation rates in apomyoglobins of buffalo, horse, and bovine mammals.
• The researchers also aimed to understand the impact of amino acid sequence differences on these rates.

Methodology

• The team conducted experiments to measure the aggregation rates of the specified apomyoglobins. These values were then compared against theoretical ones.
• The theoretical rates were evaluated considering the differences in the amino acid sequences among the species.

Findings and Conclusion

• The results indicated that specific mutations critically influence the rate-determining step of apomyoglobin aggregation.
• These mutations were primarily located within the N-terminal (beginning) region of the protein molecule.
• This means the amino acid sequence in this section plays a vital role in determining the speed of amyloid aggregation.

Overall, the research provides insights into the impact of specific mutations and amino acid sequence on the rate of amyloid aggregation in apomyoglobins. It highlights the fact that specific areas of the molecule, such as the N-terminal region, play crucial roles in these processes. The findings may assist in further understanding the pathogenesis of protein deposition disorders.